Results 201 to 210 of about 484,866 (343)

Bioprinted Constructs in the Regulatory Landscape: Current State and Future Perspectives

Advanced Materials, EarlyView.
Bioprinting has rapidly emerged as a transformative technology in biomedical research, offering unprecedented potential to replicate complex tissues. Despite its promise, clinical translation remains limited due to regulatory hurdles. This review explores global regulatory frameworks, comparing approaches in the EU, U.S., China, and Australia, and ...
Francesca Perin, Liliang Ouyang, Khoon S. Lim, Antonella Motta, Devid Maniglio, Lorenzo Moroni, Carlos Mota   +6 more
wiley   +1 more source

Erratum to Current status of dopamine agonists in Parkinson’s disease [PDF]

, 1996
J L Montastruc, Olivier Rascol, Jean‐Michel Sénard   +2 more
openalex   +1 more source

Additional file 2: of Identification of plasma microRNA expression changes in multiple system atrophy and Parkinsonâ s disease

, 2019
Table S2. Top 50 predicted target genes for each miRNA using miRmap. (DOCX 22 kb)
Uwatoko, Hisashi, Hama, Yuka, Iwata, Ikuko, Shirai, Shinichi, Matsushima, Masaaki, Yabe, Ichiro, Utsumi, Jun, Sasaki, Hidenao   +7 more
openaire   +1 more source

Kelvin Probe Force Microscopy in Bionanotechnology: Current Advances and Future Perspectives

Advanced Materials, EarlyView.
Kelvin probe force microscopy (KPFM) enables the nanoscale mapping of electrostatic surface potentials. While widely applied in materials science, its use in biological systems remains emerging. This review presents recent advances in KPFM applied to biological samples and provides a critical perspective on current limitations and future directions for
Ehsan Rahimi, Mario Palacios‐Corella, Arjan Mol, Salvador Pané, Josep Puigmartí‐Luis   +4 more
wiley   +1 more source

Botulinum Toxin for the Treatment of Tremors

Toxins
Tremor, an oscillatory movement disorder, is commonly encountered in clinical practice in the setting of a variety of etiologies, such as essential tremor and Parkinson’s disease. Despite its high prevalence, treatment options are somewhat limited.
Steven Bellows, Joseph Jankovic
doaj   +1 more source

Computer simulation of some of the motor circuits underlying Parkinson’s disease [PDF]

, 1997
Gabrielle Geller, David V. Reynolds
openalex   +1 more source

Additional file 4: of Identification of plasma microRNA expression changes in multiple system atrophy and Parkinsonâ s disease

, 2019
Table S4. Top 15 statistically significant GO processes relevant to the top 50 predicted target genes of hsa-miR-24-3p. (DOCX 18 kb)
Uwatoko, Hisashi, Hama, Yuka, Iwata, Ikuko, Shirai, Shinichi, Matsushima, Masaaki, Yabe, Ichiro, Utsumi, Jun, Sasaki, Hidenao   +7 more
openaire   +1 more source

Autonomous Implants

Advanced Materials, EarlyView.
An ideal implant should mimic native tissues such that it can integrate, sense, heal, and continue to function, i.e., be autonomous. Although early, there are good steps taken in this way, e.g., the development of stimuli‐responsive, self‐powering, self‐actuating, self‐healing, self‐regenerating, and self‐aware implants.
Jagan Mohan Dodda, Marcel F. Kunrath, Ling Zhou Zhao, Mahdi Bodaghi, Armin Yousefi, Nureddin Ashammakhi   +5 more
wiley   +1 more source

Beyond the Classic Segawa Disease, -Associated Neurodegenerative Parkinsonism: Practical Considerations for Physicians [PDF]

Journal of Movement Disorders, 2017
Jirat Chenbhanich, Jirada Sringean, Roongroj Bhidayasiri   +2 more
doaj   +1 more source

Current Issues in Neurodegenerative Diseases, Vol. 3, Parkinson’s Disease: Symptomatic Versus Preventative Therapy. Edited by E.C. Wolters, ICG Publications, Dordrecht; Current Issues in Neurodegenerative Diseases, Vol. 5, The Functional Role of Dopamine 01 Receptors. Edited by R. J. Vermeulen, ICG Publications, Dordrecht [PDF]

, 1995
R. Grünewald
openalex   +1 more source